Klisyri
Drug
Almirall LLC
Total Payments
$2.1M
Transactions
11,033
Doctors
4,299
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $433,070 | 3,250 | 1,961 |
| 2023 | $544,369 | 2,839 | 1,604 |
| 2022 | $692,289 | 3,864 | 1,911 |
| 2021 | $395,732 | 1,060 | 707 |
| 2020 | $56,462 | 20 | 12 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $856,072 | 100 | 40.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $506,023 | 194 | 23.8% |
| Consulting Fee | $392,414 | 244 | 18.5% |
| Food and Beverage | $264,907 | 10,245 | 12.5% |
| Travel and Lodging | $78,405 | 240 | 3.7% |
| Honoraria | $24,100 | 10 | 1.1% |
Payments by Type
General
$1.3M
10,933 transactions
Research
$856,072
100 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK) | Almirall LLC | $265,401 | 4 |
| PROAK | Almirall LLC | $223,535 | 1 |
| H2200555 KLISYRI-IIS US Tirba SCCIS Lain | Almirall LLC | $56,058 | 0 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Field of Cancerization Size | Almirall LLC | $50,000 | 0 |
| PhIV-IIS - RWE Tirbanibulin NMSC | Almirall LLC | $50,000 | 0 |
| IIS Dr. Lain - Tirbanibulin for sBCC – US | Almirall LLC | $37,373 | 0 |
| PhIV-IIS - RWE Tirbanibulin for Condyloma Angela Yen Moore | Almirall LLC | $28,500 | 0 |
Top Doctors Receiving Payments for Klisyri
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Charleston, SC | $794,522 | 88 |
| , M.D | Dermatology | Charleston, SC | $165,604 | 148 |
| , M.D., PH.D | Dermatology | Aventura, FL | $116,808 | 76 |
| , M.D | Dermatology | Austin, TX | $104,084 | 59 |
| , MD | Dermatology | Louisville, KY | $65,432 | 51 |
| , DO | MOHS-Micrographic Surgery | Las Vegas, NV | $62,419 | 40 |
| , MD, PA | Dermatology | Arlington, TX | $59,262 | 58 |
| , MD | Dermatology | San Diego, CA | $44,827 | 49 |
| , M.D | Dermatology | Boston, MA | $40,777 | 21 |
| , M.D | Dermatology | West Bloomfield, MI | $32,256 | 27 |
| , PA C | Physician Assistant | Gilbert, AZ | $23,148 | 31 |
| , MD | Dermatology | Winston Salem, NC | $18,000 | 4 |
| , M.D., PH.D | Student in an Organized Health Care Education/Training Program | New Haven, CT | $17,727 | 10 |
| , M.D | Dermatology | Irvine, CA | $17,238 | 24 |
| , MD | Family Medicine | Ridgeland, MS | $14,534 | 15 |
| , M.D., PH.D | Dermatology | Vienna, VA | $14,473 | 19 |
| , MD PHD | Dermatology | Palm Beach Gardens, FL | $14,075 | 7 |
| , MD | Dermatology | Washington, DC | $11,825 | 9 |
| , M.D | Dermatology | Brooklyn, NY | $11,700 | 2 |
| , M.D., M.S., A.H.E | Dermatology | Sacramento, CA | $11,275 | 7 |
| , M.D., PH.D | Dermatology | Mason, OH | $11,170 | 19 |
| , M.D | MOHS-Micrographic Surgery | Rockwall, TX | $10,938 | 13 |
| , MD | Dermatopathology | Dallas, TX | $9,200 | 4 |
| , M.D | MOHS-Micrographic Surgery | Miami, FL | $8,653 | 20 |
| , MD | Dermatology | Phoenix, AZ | $7,625 | 6 |
Ad
Manufacturing Companies
- Almirall LLC $2.1M
Product Information
- Type Drug
- Total Payments $2.1M
- Total Doctors 4,299
- Transactions 11,033
About Klisyri
Klisyri is a drug associated with $2.1M in payments to 4,299 healthcare providers, recorded across 11,033 transactions in the CMS Open Payments database. The primary manufacturer is Almirall LLC.
Payment data is available from 2020 to 2024. In 2024, $433,070 was paid across 3,250 transactions to 1,961 doctors.
The most common payment nature for Klisyri is "Unspecified" ($856,072, 40.3% of total).
Klisyri is associated with 7 research studies, including "Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK)" ($265,401).